David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.
Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.
Accessibility Tools